558 related articles for article (PubMed ID: 9843416)
61. Sequences within domain II of the urokinase receptor critical for differential ligand recognition.
Li Y; Lawrence DA; Zhang L
J Biol Chem; 2003 Aug; 278(32):29925-32. PubMed ID: 12761227
[TBL] [Abstract][Full Text] [Related]
62. Domain interplay in the urokinase receptor. Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains.
Behrendt N; Ronne E; Dano K
J Biol Chem; 1996 Sep; 271(37):22885-94. PubMed ID: 8798468
[TBL] [Abstract][Full Text] [Related]
63. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
Høyer-Hansen G; Rønne E; Solberg H; Behrendt N; Ploug M; Lund LR; Ellis V; Danø K
J Biol Chem; 1992 Sep; 267(25):18224-9. PubMed ID: 1381366
[TBL] [Abstract][Full Text] [Related]
64. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
65. Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.
Harvey SR; Nayak SK; Markus G; Ouhammouch M; Hemperly JJ; Dillman RO; Doyle DJ
Arch Biochem Biophys; 1997 Sep; 345(2):289-98. PubMed ID: 9308901
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides.
Bürgle M; Koppitz M; Riemer C; Kessler H; König B; Weidle UH; Kellermann J; Lottspeich F; Graeff H; Schmitt M; Goretzki L; Reuning U; Wilhelm O; Magdolen V
Biol Chem; 1997; 378(3-4):231-7. PubMed ID: 9165076
[TBL] [Abstract][Full Text] [Related]
67. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
68. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.
Ploug M; Kjalke M; Rønne E; Weidle U; Høyer-Hansen G; Danø K
J Biol Chem; 1993 Aug; 268(23):17539-46. PubMed ID: 8394346
[TBL] [Abstract][Full Text] [Related]
69. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
70. Intermolecular contact regions in urokinase plasminogen activator receptor.
Liang OD; Bdeir K; Matz RL; Chavakis T; Preissner KT
J Biochem; 2003 Nov; 134(5):661-6. PubMed ID: 14688231
[TBL] [Abstract][Full Text] [Related]
71. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
Nolli ML; Corti A; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):214-8. PubMed ID: 2433787
[TBL] [Abstract][Full Text] [Related]
72. Regulation of the urokinase receptor by its plasminogen activator.
Hollas W; Boyd D
Thromb Haemost; 1991 Dec; 66(6):678-83. PubMed ID: 1665597
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics.
Schmiedeberg N; Schmitt M; Rölz C; Truffault V; Sukopp M; Bürgle M; Wilhelm OG; Schmalix W; Magdolen V; Kessler H
J Med Chem; 2002 Nov; 45(23):4984-94. PubMed ID: 12408709
[TBL] [Abstract][Full Text] [Related]
74. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
Min HY; Semnani R; Mizukami IF; Watt K; Todd RF; Liu DY
J Immunol; 1992 Jun; 148(11):3636-42. PubMed ID: 1316922
[TBL] [Abstract][Full Text] [Related]
75. Structure and ligand interactions of the urokinase receptor (uPAR).
Kjaergaard M; Hansen LV; Jacobsen B; Gardsvoll H; Ploug M
Front Biosci; 2008 May; 13():5441-61. PubMed ID: 18508598
[TBL] [Abstract][Full Text] [Related]
76. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
77. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
Del Rosso M; Dini G; Fibbi G
Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
[TBL] [Abstract][Full Text] [Related]
78. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).
Longstaff C; Merton RE; Fabregas P; Felez J
Blood; 1999 Jun; 93(11):3839-46. PubMed ID: 10339491
[TBL] [Abstract][Full Text] [Related]
79. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.
Sidenius N; Andolfo A; Fesce R; Blasi F
J Biol Chem; 2002 Aug; 277(31):27982-90. PubMed ID: 12034711
[TBL] [Abstract][Full Text] [Related]
80. Structural basis of interaction between urokinase-type plasminogen activator and its receptor.
Barinka C; Parry G; Callahan J; Shaw DE; Kuo A; Bdeir K; Cines DB; Mazar A; Lubkowski J
J Mol Biol; 2006 Oct; 363(2):482-95. PubMed ID: 16979660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
